Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Türkiye

Marie Skłodowska-Curie Action · Running

NANOBIO4CAN Nanobiotechnologies for Innovative Therapeutic Approaches for Cancer

Coordinator
Sabanci Universitesi Nanoteknoloji Arastirma Ve Uygulama Merkezi Sunum, Türkiye
Runs
1 November 2023 to 31 October 2028
Status
Running
EU funding
€2.3m
Total cost
—
Partners
20 organisations in 9 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101126492

What the project is doing

In the project's own words, from its summary on CORDIS.

NANOBIO4CAN is a new collaborative research & training programme of excellence for the recruitment of 24 postdoctoral fellows in the field of “Nanobiotechnologies for Innovative Therapeutic Approaches for Cancer” led by Sabanci University Nanotechnology Research and Application Center (SUNUM) in collaboration with 3 leading Turkish research centers in life sciences: TUBITAK Marmara Research Center (TUBITAK-MAM), Koç University Research Center for Translational Medicine (KUTTAM) and Izmir Biomedicine and Genome Center (IBG).

NANOBIO4CAN focuses on cancer research while providing a tailor-made accelerator programme to educate tomorrow’s researchers in a broad set of scientific, transferable, and business skills to develop the mindset of an entrepreneur in parallel to the academic career. The programme is designed around international networking, intersectoral mobility & interdisciplinary research topics to enhance the career opportunities of experienced researchers in the global market and to reach the benefits of employing creative researchers with high professional expectations in the programme’s research priorities: Drug Development; Targeting System Development; Delivery Systems and Testing & Validation Systems.

Through the programme it is aimed to create roadmaps for the commercialization of the research outputs by licensing technologies of fellows in parallel while implementing their projects. NANOBIO4CAN will deliver impact by putting research and innovation into a new role, combined with new forms of joint efforts and collaboration, as well as by engaging citizens. This postdoctoral programme will contribute to broader the impact within Europe’s economy and society, also contributing to the essential Horizon Europe Societal Challenge “Health & wellbeing”.

The programme is also aligned with Horizon Europe’s Cancer Mission Area and its Health Global Challenge.

Who is involved

OrganisationCityCountryRole
Sabanci Universitesi Nanoteknoloji Arastirma Ve Uygulama Merkezi SunumIstanbulTürkiyeCoordinator
Universite De FribourgFribourgSwitzerlandAssociatedpartner
Msb Medical School Berlin GmbHBerlinGermanyAssociatedpartner
Dimokritio Panepistimio ThrakisKomotiniGreeceAssociatedpartner
Fondazione Istituto Italiano Di TecnologiaGenovaItalyAssociatedpartner
International Centre for Genetic Engineering and BiotechnologyTriesteItalyAssociatedpartner
Technische Universiteit EindhovenEindhovenNetherlandsAssociatedpartner
Uniwersytet Im. Adama Mickiewicza WpoznaniuPoznanPolandAssociatedpartner
Biomedicinske Centrum Slovenskej Akademie Vied, Verejna Vyskumna InstituciaBratislavaSlovakiaAssociatedpartner
Ustav Polymerov Slovenskej Akademievied Verejna Vyskumna InstituciaBratislavaSlovakiaAssociatedpartner
Atabay Kimya Sanayi Ve Ticaret A.s.IstanbulTürkiyeAssociatedpartner
Ataturk UniversityErzurumTürkiyeAssociatedpartner
Ege Teknopark Teknoloji Gelistirmebolgesi Anonim SirketiIzmirTürkiyeAssociatedpartner
Gen Era Diagnostik Saglik Hizmetleri A.s.IstanbulTürkiyeAssociatedpartner
Ilko Ilac San.ve Tic.A.S.IstanbulTürkiyeAssociatedpartner
Organo Id Biyoteknoloji Laboratuvar Hizmetleri Sanayi Ve Ticaret Anonim SirketiİzmirTürkiyeAssociatedpartner
TRUSTLIFE Ventures Lab Saglik Teknolojileri A.S.Umraniye / IstanbulTürkiyeAssociatedpartner
Turkiye Bilimsel Ve Teknolojik Arastirma KurumuAnkaraTürkiyeAssociatedpartner
Universite Sanayi Isbirligi Merkezleri DernegiAdanaTürkiyeAssociatedpartner
University of South Florida Board of TrusteesTampaUnited StatesAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI